Morse Asset Management Inc Sells 8,398 Shares of Astera Labs, Inc. $ALAB

Key Points

• Morse Asset Management trimmed its stake in Astera Labs by 30.2% in Q4, selling 8,398 shares and leaving it with 19,396 shares valued at about $3.227M.
• Astera Labs beat Q4 estimates with $0.58 EPS (vs. $0.51) and revenue of $270.6M (up 91.8% YoY), gave Q1 EPS guidance of 0.530–0.540, and trades with a consensus analyst rating of “Moderate Buy” and an average target of $199.20.
• Significant trading activity: insiders sold 1,064,888 shares (~$150.8M) last quarter (including GC and CEO sales under Rule 10b5‑1), while institutional investors own 60.47% of the stock and several funds initiated or increased positions.

Morse Asset Management Inc trimmed its position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 30.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 19,396 shares of the company's stock after selling 8,398 shares during the period. Morse Asset Management Inc's holdings in Astera Labs were worth $3,227,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of ALAB. Nordea Investment Management AB purchased a new position in Astera Labs in the fourth quarter valued at $2,028,000. Geneva Partners LLC purchased a new position in Astera Labs in the third quarter valued at $1,876,000. Numerai GP LLC boosted its holdings in Astera Labs by 153.1% in the third quarter. Numerai GP LLC now owns 13,212 shares of the company's stock valued at $2,587,000 after purchasing an additional 7,992 shares during the period. Handelsbanken Fonder AB boosted its holdings in Astera Labs by 289.5% in the third quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company's stock valued at $24,710,000 after purchasing an additional 93,800 shares during the period. Finally, Paragon Advisors LLC purchased a new position in Astera Labs in the third quarter valued at $1,829,000. 60.47% of the stock is owned by institutional investors.

Astera Labs Price Performance

Shares of NASDAQ ALAB opened at $201.25 on Tuesday. The company has a market capitalization of $34.47 billion, a price-to-earnings ratio of 164.96, a price-to-earnings-growth ratio of 3.99 and a beta of 3.34. The business has a 50-day moving average of $139.00 and a two-hundred day moving average of $153.00. Astera Labs, Inc. has a 1 year low of $63.40 and a 1 year high of $262.90.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.51 by $0.07. The company had revenue of $270.58 million during the quarter, compared to the consensus estimate of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.Astera Labs's revenue for the quarter was up 91.8% on a year-over-year basis. During the same period in the previous year, the business earned $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, equities research analysts expect that Astera Labs, Inc. will post 1.48 earnings per share for the current year.

Insiders Place Their Bets

In other news, General Counsel Philip Mazzara sold 10,000 shares of Astera Labs stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $107.77, for a total transaction of $1,077,700.00. Following the sale, the general counsel owned 118,084 shares in the company, valued at approximately $12,725,912.68. The trade was a 7.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 10,188 shares of Astera Labs stock in a transaction dated Monday, April 20th. The stock was sold at an average price of $175.45, for a total value of $1,787,484.60. Following the sale, the chief executive officer owned 4,069,134 shares in the company, valued at $713,929,560.30. This trade represents a 0.25% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,064,888 shares of company stock valued at $150,764,723 over the last quarter. Corporate insiders own 12.50% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the company. Rothschild & Co Redburn assumed coverage on Astera Labs in a report on Friday. They issued a "neutral" rating and a $153.00 target price for the company. Loop Capital assumed coverage on Astera Labs in a report on Thursday, March 5th. They issued a "buy" rating and a $250.00 target price for the company. Stifel Nicolaus set a $236.00 target price on Astera Labs in a report on Friday. Barclays set a $165.00 target price on Astera Labs in a report on Thursday, January 15th. Finally, Royal Bank Of Canada reaffirmed an "outperform" rating and set a $250.00 price target on shares of Astera Labs in a report on Tuesday, April 21st. Fifteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, Astera Labs presently has a consensus rating of "Moderate Buy" and an average target price of $199.20.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.